non small cell lung cancer metastatic
Showing 1 - 25 of 34
Response Rate in Patients With Advanced NSCLC on ICI
Recruiting
- Non Small Cell Lung Cancer Metastatic
- Diabetes Mellitus
- Pembrolizumab
-
Assiut, EgyptAssiut university
Oct 20, 2023
Non Small Cell Lung Cancer Metastatic, Brain Metastases, Adult, KRAS G12C Trial (JDQ443)
Not yet recruiting
- Non Small Cell Lung Cancer Metastatic
- +2 more
- (no location specified)
Aug 11, 2023
Non Small Cell Lung Cancer Metastatic Trial (MRI)
Not yet recruiting
- Non Small Cell Lung Cancer Metastatic
- MRI
- (no location specified)
May 16, 2023
Non Small Cell Lung Cancer Metastatic, Newly Diagnosed NSCLC, Non-Squamous Non-Small Cell Tumor of Lung Trial in United States
Not yet recruiting
- Non Small Cell Lung Cancer Metastatic
- +2 more
- iNUDGE
-
Cherry Hill, New Jersey
- +5 more
May 9, 2023
Non Small Cell Lung Cancer Metastatic Trial in Worldwide (GEN1046, Pembrolizumab)
Recruiting
- Non Small Cell Lung Cancer Metastatic
- GEN1046
- Pembrolizumab
-
Santa Rosa, California
- +26 more
Jan 30, 2023
Triple Negative Breast Cancer, TNBC - Triple-Negative Breast Cancer, NSCLC Trial in United States (LYL797)
Recruiting
- Triple Negative Breast Cancer
- +14 more
- LYL797
-
Scottsdale, Arizona
- +10 more
Jan 30, 2023
Platinum Resistant Ovarian Cancer, Non Small Cell Lung Cancer Metastatic Trial in Worldwide (upifitamab rilsodotin)
Recruiting
- Platinum Resistant Ovarian Cancer
- Non Small Cell Lung Cancer Metastatic
- upifitamab rilsodotin
-
Birmingham, Alabama
- +171 more
Jan 23, 2023
Non Small Cell Lung Cancer Metastatic Trial (Pembrolizumab, Pembrolizumab biosimilar)
Not yet recruiting
- Non Small Cell Lung Cancer Metastatic
- Pembrolizumab
- Pembrolizumab biosimilar
- (no location specified)
Dec 19, 2022
Non Small Cell Lung Cancer, Non Small Cell Lung Cancer Metastatic, Non-small Cell Carcinoma Trial in United States (radiation,
Recruiting
- Non Small Cell Lung Cancer
- +4 more
- L-SABR
- +2 more
-
Basking Ridge, New Jersey
- +6 more
Dec 20, 2022
Tumors, Metastatic Cancer, Advanced Cancer Trial in United States (Niraparib, TSR-042, Carboplatin-Paclitaxel)
Non Small Cell Lung Cancer Metastatic Trial (Pembrolizumab in Combination with Plinabulin and Docetaxel)
Not yet recruiting
- Non Small Cell Lung Cancer Metastatic
- Pembrolizumab in Combination with Plinabulin and Docetaxel
- (no location specified)
Oct 28, 2022
Non Small Cell Lung Cancer Metastatic Trial in Worldwide (Osimertinib, Bevacizumab)
Active, not recruiting
- Non Small Cell Lung Cancer Metastatic
-
Dublin, Ireland
- +24 more
Aug 23, 2022
Non Small Cell Lung Cancer Metastatic, Advanced Melanoma Trial in Toronto, Montréal, Québec (FMT + ICI)
Recruiting
- Non Small Cell Lung Cancer Metastatic
- Advanced Melanoma
- FMT + ICI
-
Toronto, Ontario, Canada
- +3 more
Aug 19, 2022
Non Small Cell Lung Cancer Metastatic Trial in France (Lorlatinib)
Recruiting
- Non Small Cell Lung Cancer Metastatic
-
Aix-en-Provence, France
- +38 more
Aug 9, 2022
Clear-Cell Metastatic Renal Cell Carcinoma, Non Small Cell Lung Cancer Metastatic, Brain Metastases, Adult Trial in Montreal,
Active, not recruiting
- Clear-Cell Metastatic Renal Cell Carcinoma
- +4 more
- Nivolumab
- Radiosurgery
-
Montreal, Quebec, Canada
- +3 more
Aug 2, 2022
Non Small Cell Lung Cancer, Non Small Cell Lung Cancer Metastatic, Non-Small Cell Carcinoma of Lung, TNM Stage 4 Trial in France
Recruiting
- Non Small Cell Lung Cancer
- +2 more
- Radiotherapy
- +2 more
-
Angers, France
- +25 more
Jul 25, 2022
TNBC - Triple-Negative Breast Cancer, Triple Negative Breast Cancer, NSCLC Trial in United States (Sterotactic Body
Active, not recruiting
- TNBC - Triple-Negative Breast Cancer
- +6 more
- Sterotactic Body Radiotherapy/SBRT
- Standard of care
-
Basking Ridge, New Jersey
- +8 more
Jul 26, 2022
Patients With Advanced Non-Small Cell Lung Cancer
Completed
- Non Small Cell Lung Cancer
- +2 more
-
Indianapolis, IndianaIndiana University Melvin & Bren Simon Cancer Center
Jul 19, 2022
Non Small Cell Lung Cancer Metastatic, Leptomeningeal Metastasis, Brain Metastases Trial in France (Osimertinib)
Recruiting
- Non Small Cell Lung Cancer Metastatic
- +3 more
-
Aix-en-Provence, France
- +36 more
Jun 28, 2022
NSCLC, Metastatic Non Small Cell Lung Cancer, Nsclc Trial in United States (Local ablative therapy, Blood collection to assess
Recruiting
- Non-small Cell Lung Cancer
- +5 more
- Local ablative therapy
- Blood collection to assess for ctDNA
-
Basking Ridge, New Jersey
- +6 more
Jun 20, 2022
Non Small Cell Lung Cancer Metastatic Trial in Morgantown (Radiation, Immuno-Therapeutic Agent)
Active, not recruiting
- Non Small Cell Lung Cancer Metastatic
- Radiation
- Immuno-Therapeutic Agent
-
Morgantown, West VirginiaWVU Cancer Institute - Mary Babb Randolph Cancer Center
Apr 25, 2022
Non Small Cell Lung Cancer Metastatic, Non Small Cell Lung Cancer Stage III, HER2 Gene Mutation Trial in France (pertuzumab +
Active, not recruiting
- Non Small Cell Lung Cancer Metastatic
- +2 more
- pertuzumab + trastuzumab + docetaxel
-
Besançon, France
- +17 more
Mar 9, 2022
Malignant Melanoma, Metastatic, Non Small Cell Lung Cancer Metastatic, Bladder Urothelial Carcinoma, Metastatic Trial in Herlev
Active, not recruiting
- Malignant Melanoma, Metastatic
- +2 more
-
Herlev, Denmark
- +1 more
Jan 10, 2022
Non Small Cell Lung Cancer Metastatic Trial in Worldwide (TG4010, Chemotherapy, Nivolumab)
Completed
- Non Small Cell Lung Cancer Metastatic
- TG4010
- +2 more
-
Charlotte, North Carolina
- +8 more
Dec 22, 2021